Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis
Current Pharmaceutical Analysis · 2025-08 · 21 (7) · 337-348
DOI: 10.1016/j.cpan.2025.06.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2025-08. Verfasst von Shiqi Ren und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ren, S., Zhu, Q., Yang, Z., Wang, Y., Li, Z., Bian, H., & Tan, J. (2025). Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis. Current Pharmaceutical Analysis, 21(7), 337-348. https://doi.org/10.1016/j.cpan.2025.06.002
Vancouver
Ren S, Zhu Q, Yang Z, Wang Y, Li Z, Bian H, et al. Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis. Current Pharmaceutical Analysis. 2025;21(7):337-348. doi:10.1016/j.cpan.2025.06.002
BibTeX
@article{Ren2025,
author = {Ren, Shiqi and Zhu, Qin and Yang, Ze and Wang, Yujing and Li, Zhenkun and Bian, Haoyu and Tan, Jun},
title = {Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis},
journal = {Current Pharmaceutical Analysis},
year = {2025},
volume = {21},
number = {7},
pages = {337--348},
doi = {10.1016/j.cpan.2025.06.002}
}
EUVIMED